{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:33:21Z","timestamp":1793162001536,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jocn.2026.112305","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:56:41Z","timestamp":1789613801000},"page":"112305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical utility of DaTscan in clinically uncertain parkinsonian syndromes: a systematic review and meta\u2011analysis"],"prefix":"10.1016","volume":"154","author":[{"given":"J.P.","family":"Rissardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Patino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.L.Fornari","family":"Caprara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"McGarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.112305_b0005","first-page":"747","article-title":"Nuclear Imaging in the Diagnosis of Clinically Uncertain Parkinsonian Syndromes","volume":"116","author":"Buchert","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jocn.2026.112305_b0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S1474-4422(16)00116-2","article-title":"The new definition and diagnostic criteria of Parkinson\u2019s disease","volume":"15","author":"Postuma","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2026.112305_b0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/jnnp.62.2.133","article-title":"[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson\u2019s disease","volume":"62","author":"Booij","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2026.112305_b0020","first-page":"16","article-title":"DaT\u2019s Awesome: Hawai\u2019i\u2019s First Dopamine Transporter (DaT) Nuclear Medicine Study","volume":"76","author":"Royston","year":"2017","journal-title":"Hawaii J Med Public Health"},{"key":"10.1016\/j.jocn.2026.112305_b0025","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3390\/clinpract13060128","article-title":"Neuroimaging Techniques in Differentiating Parkinson\u2019s Disease from Drug-Induced Parkinsonism: A Comprehensive Review","volume":"13","author":"Pitton Rissardo","year":"2023","journal-title":"Clin Pract"},{"key":"10.1016\/j.jocn.2026.112305_b0030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41531-021-00185-8","article-title":"Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis","volume":"7","author":"Bega","year":"2021","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.jocn.2026.112305_b0035","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/ene.12444","article-title":"[123I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson\u2019s disease and vascular or drug-induced parkinsonisms: a meta-analysis","volume":"21","author":"Brigo","year":"2014","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2026.112305_b0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ageing\/afy158","article-title":"Highlighting the goals for Parkinson\u2019s care: commentary on NICE Guidelines for Parkinson\u2019s in Adults (NG71)","volume":"48","author":"Brock","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.jocn.2026.112305_b0045","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1373\/clinchem.2012.182576","article-title":"Beyond diagnostic accuracy: the clinical utility of diagnostic tests","volume":"58","author":"Bossuyt","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jocn.2026.112305_b0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2026.112305_b0055","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pst.1560","article-title":"Exact likelihood ratio and score confidence intervals for the binomial proportion","volume":"12","author":"Somerville","year":"2013","journal-title":"Pharm Stat"},{"key":"10.1016\/j.jocn.2026.112305_b0060","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jrsm.1460","article-title":"Zero-cell corrections in random-effects meta-analyses","volume":"11","author":"Weber","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jocn.2026.112305_b0065","doi-asserted-by":"crossref","DOI":"10.1093\/g3journal\/jkab410","article-title":"Restricted maximum-likelihood method for learning latent variance components in gene expression data with known and unknown confounders","volume":"12","author":"Malik","year":"2022","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/j.jocn.2026.112305_b0070","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/ci960402j","article-title":"GraphPad prism, data analysis, and scientific graphing","volume":"37","author":"Swift","year":"1997","journal-title":"Journal of Chemical Information and Computer Sciences"},{"key":"10.1016\/j.jocn.2026.112305_b0075","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","article-title":"Longitudinal follow-up of SWEDD subjects in the PRECEPT Study","volume":"82","author":"Marek","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112305_b0080","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00259-002-0938-7","article-title":"Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand","volume":"29","author":"L\u00f8kkegaard","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jocn.2026.112305_b0085","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0212-6982(05)74184-7","article-title":"Utility of 123-I ioflupane SPECT in the assessment of patients with Parkinsonian syndrome and cerebral vasculopathy","volume":"24","author":"Garc\u00eda Vicente","year":"2005","journal-title":"Rev Esp Med Nucl"},{"key":"10.1016\/j.jocn.2026.112305_b0090","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1007\/s00259-005-1922-9","article-title":"The effect of levodopa therapy on dopamine transporter SPECT imaging with(123)I-FP-CIT in patients with Parkinson\u2019s disease","volume":"32","author":"Schillaci","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jocn.2026.112305_b0095","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/mds.21062","article-title":"123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism","volume":"21","author":"Gaig","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2026.112305_b0100","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s00702-005-0401-6","article-title":"Possible impact of dopamine SPECT on decision-making for drug treatment in Parkinsonian syndrome","volume":"113","author":"Hesse","year":"2006","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.jocn.2026.112305_b0105","first-page":"31","article-title":"The brain scintiscan with iodine-123-ioflupane to diagnose early Parkinson\u2019s disease; seven months follow up. First results in Bulgaria","volume":"9","author":"Piperkova","year":"2006","journal-title":"Hell J Nucl Med"},{"key":"10.1016\/j.jocn.2026.112305_b0110","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.crad.2006.10.013","article-title":"Initial clinical experience with [123I]ioflupane scintigraphy in movement disorders","volume":"62","author":"Manoharan","year":"2007","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jocn.2026.112305_b0115","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00702-007-0774-9","article-title":"Subacute hemicorporal parkinsonism in 5 patients with infarcts of the basal ganglia","volume":"114","author":"Vaamonde","year":"2007","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.jocn.2026.112305_b0120","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/mds.21771","article-title":"Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening","volume":"23","author":"Clarim\u00f3n","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2026.112305_b0125","first-page":"566","article-title":"Burguera JA","volume":"23","author":"P\u00e9rez Salda\u00f1a","year":"2008","journal-title":"Neurologia"},{"key":"10.1016\/j.jocn.2026.112305_b0130","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000115640","article-title":"Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes","volume":"59","author":"Vlaar","year":"2008","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2026.112305_b0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/00207454.2012.732976","article-title":"Is 6 months of neuroleptic withdrawal sufficient to distinguish drug-induced parkinsonism from Parkinson\u2019s disease?","volume":"123","author":"Lim","year":"2013","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jocn.2026.112305_b0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nrl.2012.05.005","article-title":"Diagnostic accuracy of 123 I-FP-CIT SPECT in diagnosing drug-induced parkinsonism: a prospective study","volume":"28","author":"Olivares Romero","year":"2013","journal-title":"Neurologia"},{"key":"10.1016\/j.jocn.2026.112305_b0145","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ultrasmedbio.2014.05.014","article-title":"Transcranial sonography and (123)I-FP-CIT single photon emission computed tomography in movement disorders","volume":"40","author":"B\u00e1rtov\u00e1","year":"2014","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jocn.2026.112305_b0150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000370116","article-title":"Is There a Role for DAT-SPECT Imaging in a Specialty Movement Disorders Practice?","volume":"15","author":"Bega","year":"2015","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.jocn.2026.112305_b0155","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/RLU.0000000000000766","article-title":"The impact of DaTscan in the diagnosis of Parkinson disease","volume":"40","author":"Gayed","year":"2015","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jocn.2026.112305_b0160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.parkreldis.2014.10.022","article-title":"Experience with DaTscan at a tertiary referral center","volume":"21","author":"Sadasivan","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jocn.2026.112305_b0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mdc3.12261","article-title":"Dopamine Transporter (DaT) Scan Utilization in a Movement Disorder Center","volume":"3","author":"Oravivattanakul","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1016\/j.jocn.2026.112305_b0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2176\/nmc.oa.2015-0234","article-title":"Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson\u2019s Disease","volume":"56","author":"Asahi","year":"2016","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.1016\/j.jocn.2026.112305_b0175","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00702-015-1419-z","article-title":"Dopamine transporter imaging in essential tremor with and without parkinsonian features","volume":"122","author":"Waln","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.jocn.2026.112305_b0180","doi-asserted-by":"crossref","first-page":"400","DOI":"10.5692\/clinicalneurol.cn-000848","article-title":"[(123)I]-Ioflupane SPECT in combination with MIBG myocardial scintigraphy in Parkinson\u2019s disease: a case series study","volume":"56","author":"Yamada","year":"2016","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jocn.2026.112305_b0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000447561","article-title":"Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center","volume":"17","author":"Graebner","year":"2017","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.jocn.2026.112305_b0190","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/aian.AIAN_497_16","article-title":"Clinical and Imaging Study of Isolated and Mixed Rest and Action Tremor-Essential Tremor versus Parkinson\u2019s Disease","volume":"20","author":"Marsala","year":"2017","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1016\/j.jocn.2026.112305_b0195","first-page":"751","article-title":"The utility of dopamine transporter scans for diagnosing Parkinsonian disorders","volume":"111","author":"Crotty","year":"2018","journal-title":"Ir Med J"},{"key":"10.1016\/j.jocn.2026.112305_b0200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/RLU.0000000000002240","article-title":"Impact of DAT-SPECT on Management of Patients Suspected of Parkinsonism","volume":"43","author":"Mirpour","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jocn.2026.112305_b0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2018.04.037","article-title":"DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice","volume":"53","author":"Yomtoob","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jocn.2026.112305_b0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1941874419829293","article-title":"Analysis of the Effect of Dopamine Transporter Scan on the Diagnosis and Management in a Tertiary Neurology Center","volume":"9","author":"Bhattacharjee","year":"2019","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.jocn.2026.112305_b0215","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/RLU.0000000000003098","article-title":"Is There Any Clinical Value of Adding 123I-Metaiodobenzylguanidine Myocardial Scintigraphy to 123I-Ioflupane (DaTscan) in the Differential Diagnosis of Parkinsonism?","volume":"45","author":"Stathaki","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jocn.2026.112305_b0220","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JPD-202506","article-title":"Impact of DaTscan Imaging on Clinical Decision Making in Clinically Uncertain Parkinson\u2019s Disease","volume":"11","author":"Isaacson","year":"2021","journal-title":"J Parkinsons Dis"},{"key":"10.1016\/j.jocn.2026.112305_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.sleepx.2024.100118","article-title":"REM sleep behavior disorder and Prodromal Parkinson\u2019s Disease in patients with Essential Tremor","volume":"8","author":"Bugalho","year":"2024","journal-title":"Sleep Med X"},{"key":"10.1016\/j.jocn.2026.112305_b0230","article-title":"Drug-Induced Parkinsonism or Parkinson\u2019s Disease: A Diagnostic Challenge in a Psychiatric Patient","volume":"17","author":"Balcerzak","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.jocn.2026.112305_b0235","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13040970","article-title":"The Utilization and Impact of Dopamine Transporter Imaging in Diagnosing Movement Disorders at a Tertiary Care Hospital in Greece","volume":"13","author":"Xiromerisiou","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.jocn.2026.112305_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/cjn.2025.10516","article-title":"Impact of DaTscan on the Management of Clinically Uncertain Parkinsonian Syndromes: A Retrospective Canadian Cohort Study","author":"Mathai Mani","year":"2026","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.jocn.2026.112305_b0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2026.112305_b0250","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.jocn.2026.112305_b0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2020.06.019","article-title":"DaTSCAN (123I-FP-CIT SPECT) imaging in early versus mid and late onset Parkinson\u2019s disease: Longitudinal data from the PPMI study","volume":"77","author":"Koros","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jocn.2026.112305_b0260","article-title":"Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson\u2019s Disease","volume":"13","author":"Pitton Rissardo","year":"2023","journal-title":"A Comprehensive Review. Brain Sci"},{"key":"10.1016\/j.jocn.2026.112305_b0265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/jnnp-2014-310256","article-title":"What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies","volume":"87","author":"Erro","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2026.112305_b0270","article-title":"Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson\u2019s disease: Analysis of the PPMI data","volume":"16","author":"Lee","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2026.112305_b0275","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ibneur.2023.10.001","article-title":"Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)","volume":"15","author":"Nabizadeh","year":"2023","journal-title":"IBRO Neurosci Rep"},{"key":"10.1016\/j.jocn.2026.112305_b0280","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2023-000600","article-title":"Long-term follow-up study of SWEDD patients with mild parkinsonian signs","volume":"6","author":"Sasaki","year":"2024","journal-title":"BMJ Neurol Open"},{"key":"10.1016\/j.jocn.2026.112305_b0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2018.01.022","article-title":"Prevalence of functional (psychogenic) parkinsonism in two Swiss movement disorders clinics and review of the literature","volume":"387","author":"Frasca Polara","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2026.112305_b0290","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1176\/appi.neuropsych.19030058","article-title":"Functional Motor Symptoms in Parkinson\u2019s Disease and Functional Parkinsonism: A Systematic Review","volume":"32","author":"Ambar Akkaoui","year":"2020","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jocn.2026.112305_b0295","article-title":"Revising a diagnosis of functional neurological disorder-a case report","volume":"2020: omaa073","author":"Berry","year":"2020","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.jocn.2026.112305_b0300","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1001\/archneur.63.8.1100","article-title":"Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor?","volume":"63","author":"Jain","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2026.112305_b0305","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14082637","article-title":"The Association Between Essential Tremor and Parkinson\u2019s Disease: A Systematic Review of Clinical and Epidemiological Studies","volume":"14","author":"Louis","year":"2025","journal-title":"J Clin Med"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682600456X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096758682600456X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:44:47Z","timestamp":1793159087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096758682600456X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":61,"alternative-id":["S096758682600456X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112305","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical utility of DaTscan in clinically uncertain parkinsonian syndromes: a systematic review and meta\u2011analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112305","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112305"}}